Charles River Laboratories Patents – Key Insights and Stats

Charles River Laboratories has a total of 512 patents globally, out of which 238 have been granted. Of these 512 patents, more than 42% patents are active. United States Of America is where Charles River Laboratories has filed the maximum number of patents, followed by Japan and Europe. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Charles River Laboratories.

Charles River Laboratories was founded in 1947 by Henry Foster. Charles River Laboratories, Inc. provides clinical tests and drug development services. The Company offers test and development services for vaccines, biosimilars, and medicine to treat cardiovascular, skeletal, endocrine, central nervous system, cancer, and other sorts of ailments. Charles River Laboratories provides their services globally.As of April 2022 Charles River Laboratories has a market cap of $14.76 Billion.

Do read about some of the most popular patents of Charles River Laboratories which have been covered by us in this article and also you can find Charles River Laboratories patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Charles River Laboratories patent portfolio.

How many patents does the Founder and CEO of Charles River Laboratories have?

The Founder & CEO, Henry Foster and James C. Foster has 0 patents.

How many patents does Charles River Laboratories have?

Charles River Laboratories has a total of 512 patents globally. These patents belong to 141 unique patent families. Out of 512 patents, 218 patents are active.

How Many Patents did Charles River Laboratories File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCharles River Laboratories Applications FiledCharles River Laboratories Patents Granted
2010163
2011468
2012416
2013566
20147424
20152130
20161721
20172516
2018823
2019612
2020164
2021512
20222

How many Charles River Laboratories patents are Alive/Dead?

Worldwide Patents

How Many Patents did Charles River Laboratories File in Different Countries?

Countries in which Charles River Laboratories Filed Patents

CountryPatents
United States Of America1250
Europe683
Germany383
China362
Japan351
Canada291
Australia195
India54
Singapore43
Hong Kong (S.A.R.)43
Spain40
France37
Austria34
Korea (South)23
Brazil18
Russia12
Denmark12
Mexico11
New Zealand8
United Kingdom7
Israel7
Portugal6
Poland4
South Africa2
Taiwan1
Netherlands1
Argentina1
Norway1
Czech Republic1
Hungary1

Where are Research Centers of Charles River Laboratories Patents Located?

10 Best Charles River Laboratories Patents

US6429013B1 is the most popular patent in the Charles River Laboratories portfolio. It has received 325 citations so far from companies like Imaging Therapeutics and Medtronic Vascular.

Below is the list of 10 most cited patents of Charles River Laboratories:

Publication NumberCitation Count
US6429013B1325
US6555374B1278
US6391297B1201
US20120019559A1195
WO2015069770A1143
US6841150B2139
US7078232B2119
US7033587B268
US20150202291A155
USD472324S154

What Percentage of Charles River Laboratories US Patent Applications were Granted?

Charles River Laboratories (Excluding its subsidiaries) has filed 70 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 42 have been granted leading to a grant rate of 77.78%.

Below are the key stats of Charles River Laboratories patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Charles River Laboratories?

Law FirmTotal ApplicationsSuccess Rate
Goodwin Procter3064.29%
Wilson Sonsini Goodrich & Rosati15100.00%
Dechert6100.00%
Sterne Kessler Goldstein & Fox4100.00%
Element Ip20%
Lathrop Gpm20%
Choate Shire1100.00%
Cooley1100.00%
Foley Hoag10%
Genzyme1100.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are Charles River Laboratories’ key innovation segments?

What Technologies are Covered by Charles River Laboratories?

The chart below distributes patents filed by Charles River Laboratories in different countries on the basis of the technology protected in patents. It also represents the markets where Charles River Laboratories thinks it’s important to protect particular technology inventions.

R&D Focus: How has Charles River Laboratories’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Charles River Laboratories?

Related Articles

Azelio Patents – Insights & Stats (Updated 2024)

Azelio has a total of 72 patents globally, out of which 39 have been granted. Of these 72 patents, more than 62% patents are active. Sweden is where Azelio has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, Sweden seems to be the main focused

Read More »

Flatfrog Lab Patents – Insights & Stats (Updated 2024)

Flatfrog Lab has a total of 617 patents globally, out of which 257 have been granted. Of these 617 patents, more than 21% patents are active. United States of America is where Flatfrog Lab has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Sweden seems

Read More »

Luzerne Patents – Insights & Stats (Updated 2024)

Luzerne has a total of 9 patents globally, out of which all patents have been granted. Of these 9 patents, all patents are active. Singapore is where Luzerne has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the origin

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.